[Anticoagulation in cardiac pathologies (except atrial fibrillation)]

P Lefebvre1, A Friart

  • 1Département de Cardiologie, C.H.U. Tivoli, La Louvière, U.L.B.

Insights

Anticoagulant therapies, like heparins and antivitamins K, are crucial in cardiology. New uses are emerging, but careful benefit-risk assessment is vital for conditions like valvular prosthesis and dilated cardiomyopathy.

Area of Science:

  • Cardiology
  • Pharmacology

Context:

  • Anticoagulants, including heparins and vitamin K antagonists, are widely used in cardiovascular medicine.
  • Established treatment guidelines exist, but new indications are continually emerging.
  • The role of anticoagulation in various cardiac conditions requires ongoing evaluation.

Purpose:

  • To review current and emerging indications for anticoagulant therapy in cardiology.
  • To emphasize the importance of benefit-risk assessment in prescribing anticoagulants.
  • To provide guidance on anticoagulant use in specific cardiac conditions.

Summary:

  • Oral anticoagulants significantly reduce thromboembolic risk in patients with cardiac valvular prostheses.
  • For non-operated valvulopathy, anticoagulant indication requires individualized benefit-risk evaluation.
  • Anticoagulant prescription in dilated cardiomyopathy should be restricted to high-embolic-risk patients.
  • Indications beyond atrial fibrillation necessitate careful consideration.

Impact:

  • Informs clinical decision-making regarding anticoagulant use in complex cardiac cases.
  • Highlights the need for personalized medicine approaches in cardiovascular pharmacotherapy.
  • Contributes to optimizing patient outcomes by managing thromboembolic risks effectively.

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...